Dr. David Elkayam
Claim this profileGSK Investigational Site
Studies Asthma
Studies Chronic Bronchitis
6 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials David Elkayam is currently running
Salbutamol Inhalers
for Asthma
The goal of this study is to assess and compare the safety and tolerability of salbutamol administered via metered dose inhaler (MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged \>=18 years with asthma.
Recruiting2 awards Phase 3
Depemokimab
for Asthma
This trial is testing a new medication called Depemokimab for people with severe asthma who have high levels of certain white blood cells. The goal is to see if switching to Depemokimab works as well as their current treatments. The medication aims to reduce these white blood cells to help control asthma symptoms.
Recruiting1 award Phase 36 criteria
More about David Elkayam
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments David Elkayam has experience with
- GSK3511294 (Depemokimab)
- SIVA-MVP
- Mepolizumab
- Benralizumab
- Pre-filled Syringes (PFS)
- LOU064
Breakdown of trials David Elkayam has run
Chronic Bronchitis
Chronic Cough
Chronic Urticaria
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Elkayam specialize in?
David Elkayam focuses on Asthma and Chronic Bronchitis. In particular, much of their work with Asthma has involved treating patients, or patients who are undergoing treatment.
Is David Elkayam currently recruiting for clinical trials?
Yes, David Elkayam is currently recruiting for 3 clinical trials in Bellingham Washington. If you're interested in participating, you should apply.
Are there any treatments that David Elkayam has studied deeply?
Yes, David Elkayam has studied treatments such as GSK3511294 (Depemokimab), SIVA-MVP, Mepolizumab.
What is the best way to schedule an appointment with David Elkayam?
Apply for one of the trials that David Elkayam is conducting.
What is the office address of David Elkayam?
The office of David Elkayam is located at: GSK Investigational Site, Bellingham, Washington 98225 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.